Composition and form of release of Osimert
The antitumor agent has a high inhibitory activity against EGFR (epidermal growth factor receptor). With a sensitizing mutation, T790M in the EGFR gene inhibits the growth of abnormal cells, due to which the growth of a neoplasm in one or both lungs stops. The drug is prescribed for both locally advanced and metastatic cancer. The main active su